Immunotherapy for clinical research

The CliniMACS® System offers a versatile range of clinical-grade cell separation reagents, which can be used within the scope of a variety of clinical protocols, such as for hematological malignancies, immunotherapy of solid tumors, viral infections, as well as autoimmune diseases, and solid organ transplantation (SOT). Using CliniMACS Reagents for preparation of DLI in the transplant and non-transplant setting allows the design of tailored cellular products according to the needs of a specific treatment.

Combining the CliniMACS^® System with the MACS^® GMP Product Line enables GMP-compliant and fully automated manufacturing of cellular products including cultivation and expansion.

For complete regulatory notices click here.